Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Oxytocin sale to be...

    Oxytocin sale to be regulated in Punjab

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-09-18T09:36:31+05:30  |  Updated On 18 Sept 2018 9:36 AM IST
    Oxytocin sale to be regulated in Punjab

    Punjab: Aiming to put a check on misuse of Oxytocin, the State government has devised stringent measures to regulate Oxytocin sale in Punjab, informed KS Pannu Commissioner Food and Drug Administration Punjab.


    He informed that the government has mandated via a notification that Oxytocin formulations shall be manufactured by public sector undertakings licensed under the Drugs and Cosmetics Rules 1945.


    Accordingly, Union government has notified Karnataka Antibiotics and Pharmaceuticals Limited( KAPL ) a Public Sector Company for manufacturing Oxytocin drug. Further, Union Health and Family Welfare ministry has shifted Oxytocin drug from Schedule H in Drugs and Cosmetics Rules,1945 to Schedule H1 of the same rules implying that it can be sold or distributed by authorised chemists and health Institutions on the basis of a written prescription of a doctor and a daily stock register with regard to Schedule H1 drugs shall be maintained.


    Read Also: Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it


    "Since Oxytocin has the potential of grave misuse causing harm to animals and humans, Drug Administration Punjab will keep a tab on the procurement of the drug in Punjab through direct communication with KAPL. Thereafter, its distribution within the State will be monitored and the retail sale will be under strict vigil. Gone are the days of off the shelf sale of Oxytocin drug," said Pannu, adding that it will be sold by the chemists having proper purchase documents and they would then sell it only on the due prescription of a physician.


    Exhorting the concerned to stick by the regulations, Pannu said that any violation of instructions should invite strict legal action against the delinquents as per the provisions of the Drug and Cosmetics Act,1940.

    Drugs and Cosmetics RulesFood and Drug AdministrationKAPLKarnataka Antibiotics and Pharmaceuticals LimitedKS PannuOxytocinOxytocin banOxytocin salePunjab
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok